The implications of ageing and life expectancy in prostate cancer treatment
Authors:
- 22 March 2016
- journal article
- review article
- Published by Springer Nature in Nature Reviews Urology
- Vol. 13 (5) , 289-295
Abstract
In patients diagnosed with prostate cancer, the selection of treatment, including the type of therapy and its aggressiveness, is often based on a patient's age and life expectancy. Life expectancy estimates are too often calculated solely on the patient's chronological age, overlooking comorbid conditions and their severity, which can greatly affect life expectancy. If, in addition to chronological age, comorbid conditions are used to assess a patient's life expectancy, the most appropriate treatment options are more likely to be selected. Older, healthy patients might be able to tolerate more aggressive treatment than would be administered on the basis of their age alone, and younger patients with numerous comorbid conditions could avoid harsh therapy that might not be appropriate given their current state of health. The key idea to consider in treatment selection is what a patient's quality of life would be like with or without a particular treatment option. In an era of precision medicine, decisions regarding the provision of health care should be made rationally and on the basis of objective estimates of the threat of disease and the benefits and costs of intervention and within the context of the patient's characteristics and desires.Keywords
This publication has 51 references indexed in Scilit:
- The Importance of Accurate Life Expectancy Prediction in Men with Prostate CancerEuropean Urology, 2015
- The Global Burden of Cancer 2013JAMA Oncology, 2015
- Cardiovascular Mortality in Patients With Metastatic Prostate Cancer Exposed to Androgen Deprivation Therapy: A Population-Based StudyClinical Genitourinary Cancer, 2015
- How we treat early systemic prostate cancer in older menJournal of Geriatric Oncology, 2014
- Use of Geriatric Assessment for Older Adults in the Oncology Setting: A Systematic ReviewJNCI: Journal of the National Cancer Institute, 2012
- Association of Comorbidities With Overall Survival in Myelodysplastic Syndrome: Development of a Prognostic ModelJournal of Clinical Oncology, 2011
- Impact of Age at Diagnosis on Prostate Cancer Treatment and SurvivalJournal of Clinical Oncology, 2011
- Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular RiskCirculation, 2010
- Radical prostatectomy in men aged ≥70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogramBJU International, 2008
- Assessment of prognosis with the total illness burden index for prostate cancerCancer, 2007